AstraZeneca and POZEN Inc. today announced the U.S. Food and Drug Administration has approved VIMOVO�� delayed-release tablets for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

Pozen Inc. and AstraZeneca Plc won U.S. clearance to sell an arthritis drug that combines a painkiller with an ulcer medication.

AstraZeneca Plc and Pozen Inc. won U.S. clearance to sell an arthritis drug that combines a painkiller with an ulcer medication.

Researchers from University of South Florida College of Medicine found a combination of antibiotics to be an effective treatment for Chlamydia-induced reactive arthritis, a major step forward in the management, and possibly cure, of this disease. Results of this study are published in the May issue of Arthritis Rheumatism, a journal of the American College of Rheumatology. Reactive arthritis ...

A new study released by Dr. Najia Shakoor, a rheumatologist at Rush University Medical Center in Chicago, states that flexible shoes may be easier on the knees and reduces the pain felt by an individual suffering from arthritis.